Tañajoras, Mark Gede L.

HRN: 23-81-59  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2023
CEFUROXIME 750MG (VIAL)
10/02/2023
10/08/2023
IVTT
750
Q8
Acute Appendicitis
Waiting Final Action 
10/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2023
10/08/2023
IVTT
250 Mg
Q8
Acute Appendicitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: